Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

205 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

UNITED KINGDOM

Greater London
LONDON

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberHCQ4Surfdefect: Hydroxychloroquine (HCQ) in pediatric ILD (interstitial lung disease) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Pulmologie, Allergologie und Endokrinologie

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Recruiting trial
Ongoing trial
ProCoCo: Procollagen-3 Driven Corticosteroids for Persistent Acute Respiratory Distress Syndrome
CHU de Marseille - Hôpital Nord
Service de réanimation médicale détresses respiratoires - Infections sévères

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
ABASARC: Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis
Klinik für Pneumologie am Universitätsklinikum Freiburg
Klinik für Pneumologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Nordrhein-Westfalen
ESSEN

GERMANY

Schleswig-Holstein
LÜBECK

Ongoing trial
IMPALA-X: An Open-label, Non-controlled, Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients -DE-
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Medizinische Klinik III - Pneumologie, Infektiologie

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Norfolk
NORWICH

BELGIUM

VLAAMS BRABANT
LEUVEN

Ongoing trial
Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders - BE
University Hospitals Leuven - Gasthuisberg
Centrum metabole ziekten - UZ Leuven

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
EXAFIP : Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial (Phase III)
Groupe hospitalier AP-HP.6 - Hôpital Tenon
Unité Pneumologie - Oncologie Thoracique - Maladies Pulmonaires Rares

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Hessen
FRANKFURT AM MAIN

Recruiting trial
Ongoing trial
gene therapy for X-CGD (X-CGD-Version2): A Phase I/II Gene Therapy Trial for X-CGD With a SIN Gammaretroviral Vector - DE
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Medizinische Klinik II - Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie

GERMANY

Hessen
FRANKFURT AM MAIN

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberPhase I/II G1XCGD.01 Sudy: Phase I/II, Non Randomized, Multicenter, Open-label Study of g1xcgd (Lentiviral Vector Transduced cd34+ Cells) in Patients with X-linked Chronic Granulomatous Disease - DE
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Medizinische Klinik II - Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie

GERMANY

Hessen
GIEßEN

Ongoing trial
An open-label extension trial of the long term safety of oral BIBF 1120 in patients with Idiopathic Pulmonary Fibrosis (Phase III) - DE
Med. Klinik und Poliklinik II des UKGM am Standort Gießen
Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen

GERMANY

Nordrhein-Westfalen
ESSEN

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis (Phase II-III) - ES
Hospital Universitario y Politécnico La Fe
Servicio de Pediatría

SPAIN

Madrid
MADRID

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
Phase I/II Gene Therapy Study for X-linked Chronic Granulomatous Disease in Children
GOSH NHS Foundatin Trust
Molecular and Cellular Immunology Unit

UNITED KINGDOM

Nottinghamshire
NOTTINGHAM

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
PEXIVAS: Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial (phase III) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

ITALY

CAMPANIA
NAPOLI

Ongoing trial
Efficacy and safety of treatment with miglustat in patients with Niemann-Pick disease type c
Azienda Ospedaliera Universitaria "Federico II"
Laboratorio Dipartimento di Pediatria

ITALY

FRIULI VENEZIA GIULIA
UDINE

ITALY

PUGLIA
BARI

Recruiting trial
Ongoing trial
Combined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

NETHERLANDS

Utrecht
UTRECHT

Ongoing trial
B-Vit in JIA: Modulating regulatory T cell function in JIA with Vitamin B3 (nicotinamide) treatment
UMC Utrecht - Universitair Medisch Centrum Utrecht
Kinderreumacentrum

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
CHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

NETHERLANDS

Groningen
GRONINGEN

Multinational clinical trial(s)

UNITED KINGDOM

Greater London
LONDON

DeVENT: Decision Support System to Evaluate VENTilation in ARDS (acute respiratory distress syndrome)
Imperial College London, main campus
Imperial College London Headquarters

FRANCE

ILE-DE-FRANCE
EVRY